Head lice: updated statementThe Canadian Paediatric Society has issued a revised statement on the diagnosis and management of head lice. Revlimid approved for multiple myelomaCelgene's Revlimid (lenalidomide 15 mg and 25 mg capsules) is now indicated for the treatment of multiple myeloma (in combination with dexamethasone) in patients who have received at least one prior therapy. Health organizations join hands to promote safe medication use CPhA, CMA join forces with Rx&D to promote safe and appropriate medication use among Canadians. Air travel during pregnancy Air travel during pregnancy has not been shown to increase the rate of miscarriage in pregnant women, according to the Motherisk Program at Toronto's Hospital for Sick Children. Ont. survey shows painkiller addiction growing concern Team-based approach to treatment could help. Editorial: The long and wired road Technology will drive an integrated healthcare system, but how long can we wait? Practice Issues: Medication forum - Adolescents, young adults and STIs Risks and recommendations for treatment, prevention of STIs. Practice Issues: Adverse reactions - ACEI- and ARB-induced angioedema Angioedema is a self-limiting, nonpitting edema that occurs in the skin and mucous membranes. Spotlight: Lighting a spark in the profession Susan Beresford juggles involvement in six professional bodies, in addition to her full-time job as dispensary manager. Colorecetal cancer Early detection, treatment and management of side effects. First Previous 2250 2251 2252 2253 2254 Next Last
